PMC:7600245 / 53619-53961 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T236","span":{"begin":229,"end":232},"obj":"Body_part"}],"attributes":[{"id":"A236","pred":"fma_id","subj":"T236","obj":"http://purl.org/sig/ont/fma/fma24890"}],"text":"Therefore, intravenously administered famotidine with standard of care (orally administered hydroxychloroquine and has progressed to include remdesivir) is currently being studied in a multi-site, randomized, double-blind, multi-arm historical control, comparative trial that is sponsored by Northwell Health, New York (NCT04370262; n = 942)."}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T20","span":{"begin":229,"end":232},"obj":"Body_part"}],"attributes":[{"id":"A20","pred":"uberon_id","subj":"T20","obj":"http://purl.obolibrary.org/obo/UBERON_0001460"}],"text":"Therefore, intravenously administered famotidine with standard of care (orally administered hydroxychloroquine and has progressed to include remdesivir) is currently being studied in a multi-site, randomized, double-blind, multi-arm historical control, comparative trial that is sponsored by Northwell Health, New York (NCT04370262; n = 942)."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T541","span":{"begin":115,"end":118},"obj":"http://purl.obolibrary.org/obo/CLO_0051582"},{"id":"T542","span":{"begin":183,"end":184},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T543","span":{"begin":229,"end":232},"obj":"http://www.ebi.ac.uk/efo/EFO_0001410"}],"text":"Therefore, intravenously administered famotidine with standard of care (orally administered hydroxychloroquine and has progressed to include remdesivir) is currently being studied in a multi-site, randomized, double-blind, multi-arm historical control, comparative trial that is sponsored by Northwell Health, New York (NCT04370262; n = 942)."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T69341","span":{"begin":38,"end":48},"obj":"Chemical"},{"id":"T6716","span":{"begin":92,"end":110},"obj":"Chemical"},{"id":"T50648","span":{"begin":141,"end":151},"obj":"Chemical"}],"attributes":[{"id":"A87304","pred":"chebi_id","subj":"T69341","obj":"http://purl.obolibrary.org/obo/CHEBI_4975"},{"id":"A41136","pred":"chebi_id","subj":"T6716","obj":"http://purl.obolibrary.org/obo/CHEBI_5801"},{"id":"A99139","pred":"chebi_id","subj":"T50648","obj":"http://purl.obolibrary.org/obo/CHEBI_145994"}],"text":"Therefore, intravenously administered famotidine with standard of care (orally administered hydroxychloroquine and has progressed to include remdesivir) is currently being studied in a multi-site, randomized, double-blind, multi-arm historical control, comparative trial that is sponsored by Northwell Health, New York (NCT04370262; n = 942)."}

{"project":"LitCovid-sentences","denotations":[{"id":"T399","span":{"begin":0,"end":342},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Therefore, intravenously administered famotidine with standard of care (orally administered hydroxychloroquine and has progressed to include remdesivir) is currently being studied in a multi-site, randomized, double-blind, multi-arm historical control, comparative trial that is sponsored by Northwell Health, New York (NCT04370262; n = 942)."}

{"project":"LitCovid-PubTator","denotations":[{"id":"1665","span":{"begin":38,"end":48},"obj":"Chemical"},{"id":"1666","span":{"begin":92,"end":110},"obj":"Chemical"},{"id":"1667","span":{"begin":141,"end":151},"obj":"Chemical"}],"attributes":[{"id":"A1665","pred":"tao:has_database_id","subj":"1665","obj":"MESH:D015738"},{"id":"A1666","pred":"tao:has_database_id","subj":"1666","obj":"MESH:D006886"},{"id":"A1667","pred":"tao:has_database_id","subj":"1667","obj":"MESH:C000606551"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Therefore, intravenously administered famotidine with standard of care (orally administered hydroxychloroquine and has progressed to include remdesivir) is currently being studied in a multi-site, randomized, double-blind, multi-arm historical control, comparative trial that is sponsored by Northwell Health, New York (NCT04370262; n = 942)."}